Email Address

info@myglpstore.com

Phone Number

+1 (904) 942-2327

Our Location

8102 Blanding blvd. Jacksonville, FL 32244

Tirzepatide 5mg -Research Compound

Sale!
Rated 5 out of 5

Tirzepatide 5mg -Research Compound

Price range: $75.00 through $720.00

Quantity
Wishlist

Tirzepatide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.

Ingredients / Composition:

ComponentDescription
Active CompoundTirzepatide (synthetic dual-agonist peptide for GLP-1 and GIP receptors)
Net Peptide Content5 mg per vial
FormLyophilized powder
ExcipientsNone added unless otherwise specified
Purity VerificationAnalytical confirmation via HPLC or mass spectrometry

Tirzepatide is referenced in scientific literature for studies examining receptor binding kinetics, intracellular signaling activation, and metabolic pathway modulation. All references are provided strictly for scientific context and experimental design and are not intended as dosing or usage guidance.

Product Usage Disclaimer:

This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.

Quick Payment

100% New

Fast Delivery

Tirzepatide 5 mg — Research Peptide for Laboratory Use Only

Tirzepatide is a dual-agonist peptide designed for laboratory research into GLP-1 and GIP receptor signaling pathways. Its molecular structure allows researchers to study ligand-receptor interactions, intracellular signal transduction, and metabolic pathway dynamics in controlled experimental systems.

Research Applications

Tirzepatide may be utilized in experimental studies including:

  • GLP-1 and GIP receptor binding affinity and kinetics

  • Intracellular signaling pathway analysis

  • Secondary messenger and gene expression response evaluation

  • Comparative dual-agonist peptide structure–activity research

  • Stability, degradation, and formulation studies

These studies support mechanistic investigations into dual-incretin receptor function and related cellular signaling networks.


Storage & Laboratory Handling

Store under laboratory-appropriate cold conditions to maintain peptide stability. Handle using standard laboratory peptide protocols. Reconstitution, aliquoting, and storage should follow institutional guidelines.


Research-Only Disclaimer

This product is provided strictly for laboratory and scientific research use. Not intended for:

  • Human consumption

  • Animal use

  • Diagnostic procedures

  • Therapeutic or clinical applications

No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for institutional and regulatory compliance when handling investigational compounds.

Tirzepatide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.

Ingredients / Composition:

ComponentDescription
Active CompoundTirzepatide (synthetic dual-agonist peptide for GLP-1 and GIP receptors)
Net Peptide Content5 mg per vial
FormLyophilized powder
ExcipientsNone added unless otherwise specified
Purity VerificationAnalytical confirmation via HPLC or mass spectrometry

Tirzepatide is referenced in scientific literature for studies examining receptor binding kinetics, intracellular signaling activation, and metabolic pathway modulation. All references are provided strictly for scientific context and experimental design and are not intended as dosing or usage guidance.

  • Description

    Tirzepatide 5 mg — Research Peptide for Laboratory Use Only

    Tirzepatide is a dual-agonist peptide designed for laboratory research into GLP-1 and GIP receptor signaling pathways. Its molecular structure allows researchers to study ligand-receptor interactions, intracellular signal transduction, and metabolic pathway dynamics in controlled experimental systems.

    Research Applications

    Tirzepatide may be utilized in experimental studies including:

    • GLP-1 and GIP receptor binding affinity and kinetics

    • Intracellular signaling pathway analysis

    • Secondary messenger and gene expression response evaluation

    • Comparative dual-agonist peptide structure–activity research

    • Stability, degradation, and formulation studies

    These studies support mechanistic investigations into dual-incretin receptor function and related cellular signaling networks.


    Storage & Laboratory Handling

    Store under laboratory-appropriate cold conditions to maintain peptide stability. Handle using standard laboratory peptide protocols. Reconstitution, aliquoting, and storage should follow institutional guidelines.


    Research-Only Disclaimer

    This product is provided strictly for laboratory and scientific research use. Not intended for:

    • Human consumption

    • Animal use

    • Diagnostic procedures

    • Therapeutic or clinical applications

    No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for institutional and regulatory compliance when handling investigational compounds.

  • Additional Information

    Tirzepatide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.

    Ingredients / Composition:

    ComponentDescription
    Active CompoundTirzepatide (synthetic dual-agonist peptide for GLP-1 and GIP receptors)
    Net Peptide Content5 mg per vial
    FormLyophilized powder
    ExcipientsNone added unless otherwise specified
    Purity VerificationAnalytical confirmation via HPLC or mass spectrometry

    Tirzepatide is referenced in scientific literature for studies examining receptor binding kinetics, intracellular signaling activation, and metabolic pathway modulation. All references are provided strictly for scientific context and experimental design and are not intended as dosing or usage guidance.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.